Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade

Immunotherapy using checkpoint blockade has revolutionized cancer treatment, improving patient survival and quality of life. Nevertheless, the clinical outcomes of such immunotherapy are highly heterogeneous between patients. Depending on the cancer type, the patient response rates to this immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuang, Yu-Chen, Tseng, Jen-Chih, Huang, Li-Rung, Huang, Chun-Ming, Huang, Chi-Ying F., Chuang, Tsung-Hsien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274158/
https://www.ncbi.nlm.nih.gov/pubmed/32547560
http://dx.doi.org/10.3389/fimmu.2020.01075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274158/
https://www.ncbi.nlm.nih.gov/pubmed/32547560
http://dx.doi.org/10.3389/fimmu.2020.01075

Ejemplares similares